CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Deferred Revenue
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Deferred Revenue of -$18.29 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-10
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$18.29M, a 546.80% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for the quarter ending 2017-04-01 was $4.09M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was $12.41M, a 147.28% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for the quarter ending 2016-09-24 was $1.14M, a 37.33% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for fiscal 2016 was $14.58M, a 132.39% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for fiscal 2015 was $6.27M, a 71.79% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for fiscal 2014 was $22.24M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in deferred revenue for fiscal 2013 was -$3.30M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|---|
| 2018-03-31 | -$18.29M 10-Q · filed 2018-05-10 | |||||
| 2017-04-01 | $4.09M 10-Q · filed 2018-05-10 | $16.50M derived: sum of 2 quarters · filed 2018-05-10 | $17.65M derived: sum of 3 quarters · filed 2018-05-10 | $19.65M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $13.55M derived: sum of 2 quarters · filed 2017-02-14 | $15.56M derived: sum of 3 quarters · filed 2017-02-14 | $14.58M 10-K · filed 2017-02-14 | ||
| 2016-09-24 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $3.15M derived: sum of 2 quarters · filed 2016-11-02 | $2.17M 10-Q · filed 2016-11-02 | $7.19M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2016-06-25 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.02M 10-Q · filed 2016-08-03 | $6.04M derived: sum of 3 quarters · filed 2017-02-14 | $6.88M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2016-03-26 | -$979.00K 10-Q · filed 2016-05-04 | $4.04M derived: sum of 2 quarters · filed 2017-02-14 | $4.87M derived: sum of 3 quarters · filed 2017-02-14 | $3.97M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-12-26 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.85M derived: sum of 2 quarters · filed 2017-02-14 | $4.95M derived: sum of 3 quarters · filed 2017-02-14 | $6.27M 10-K · filed 2017-02-14 | ||
| 2015-09-26 | $833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$66.00K derived: sum of 2 quarters · filed 2016-11-02 | $1.25M 10-Q · filed 2016-11-02 | $14.67M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-06-27 | -$899.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $422.00K 10-Q · filed 2016-08-03 | $13.84M derived: sum of 3 quarters · filed 2017-02-14 | $20.72M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-03-28 | $1.32M 10-Q · filed 2016-05-04 | $14.74M derived: sum of 2 quarters · filed 2017-02-14 | $21.62M derived: sum of 3 quarters · filed 2017-02-14 | $22.95M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2014-12-27 | $13.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $20.30M derived: sum of 2 quarters · filed 2017-02-14 | $21.63M derived: sum of 3 quarters · filed 2017-02-14 | $22.24M 10-K · filed 2017-02-14 | ||
| 2014-09-27 | $6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $8.21M derived: sum of 2 quarters · filed 2015-11-04 | $8.83M 10-Q · filed 2015-11-04 | $7.82M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-28 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.94M 10-Q · filed 2015-07-30 | $934.00K derived: sum of 3 quarters · filed 2016-02-12 | $1.51M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-29 | $615.00K 10-Q · filed 2015-04-30 | -$393.00K derived: sum of 2 quarters · filed 2016-02-12 | $182.00K derived: sum of 3 quarters · filed 2016-02-12 | $1.21M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-28 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$433.00K derived: sum of 2 quarters · filed 2016-02-12 | $591.00K derived: sum of 3 quarters · filed 2016-02-12 | -$3.30M 10-K · filed 2016-02-12 | ||
| 2013-09-28 | $575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.60M derived: sum of 2 quarters · filed 2014-10-30 | -$2.29M 10-Q · filed 2014-10-30 | -$3.49M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2013-06-29 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.86M 10-Q · filed 2014-08-07 | -$4.06M derived: sum of 3 quarters · filed 2015-02-17 | -$8.13M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2013-03-30 | -$3.89M 10-Q · filed 2014-04-30 | -$5.09M derived: sum of 2 quarters · filed 2015-02-17 | -$9.15M derived: sum of 3 quarters · filed 2015-02-17 | -$5.77M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2012-12-29 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$5.26M derived: sum of 2 quarters · filed 2015-02-17 | -$1.88M derived: sum of 3 quarters · filed 2015-02-17 | -$915.00K 10-K · filed 2015-02-17 | ||
| 2012-09-29 | -$4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$680.00K derived: sum of 2 quarters · filed 2013-10-30 | $283.00K 10-Q · filed 2013-10-30 | $3.17M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $4.35M 10-Q · filed 2013-07-31 | $7.23M derived: sum of 3 quarters · filed 2014-02-25 | $3.72M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $963.00K 10-Q · filed 2013-05-08 | $3.85M derived: sum of 2 quarters · filed 2014-02-25 | $330.00K derived: sum of 3 quarters · filed 2014-02-25 | -$479.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$633.00K derived: sum of 2 quarters · filed 2014-02-25 | -$1.44M derived: sum of 3 quarters · filed 2014-02-25 | -$9.52M 10-K · filed 2014-02-25 | ||
| 2011-09-24 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$4.33M derived: sum of 2 quarters · filed 2012-11-01 | -$12.40M 10-Q · filed 2012-11-01 | -$7.38M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-25 | -$809.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$8.88M 10-Q · filed 2012-08-07 | -$3.87M derived: sum of 3 quarters · filed 2013-02-27 | -$2.97M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-26 | -$8.07M 10-Q · filed 2012-05-04 | -$3.06M derived: sum of 2 quarters · filed 2013-02-27 | -$2.16M derived: sum of 3 quarters · filed 2013-02-27 | -$8.37M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-25 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $5.91M derived: sum of 2 quarters · filed 2013-02-27 | -$300.00K derived: sum of 3 quarters · filed 2013-02-27 | -$4.21M 10-K · filed 2013-02-27 | ||
| 2010-09-25 | $894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$5.32M derived: sum of 2 quarters · filed 2011-11-02 | -$9.22M 10-Q · filed 2011-11-02 | -$10.24M 10-Q · filed 2010-11-04 | -$9.71M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-06-26 | -$6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$10.12M 10-Q · filed 2011-08-03 | -$10.74M 10-Q · filed 2010-08-03 | -$10.61M derived: sum of 3 quarters · filed 2012-02-27 | -$12.82M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-03-27 | -$3.91M 10-Q · filed 2011-05-04 | -$4.40M derived: sum of 2 quarters · filed 2012-02-27 | -$6.61M derived: sum of 3 quarters · filed 2012-02-27 | |||
| 2009-12-26 | -$487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$2.70M derived: sum of 2 quarters · filed 2012-02-27 | -$14.47M 10-K · filed 2012-02-27 | |||
| 2009-09-26 | -$2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$13.98M 10-Q · filed 2010-11-04 | ||||
| 2009-06-27 | -$11.77M 10-Q · filed 2010-08-03 | |||||
| 2008-12-27 | -$15.13M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |